相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Imaging pathophysiological changes in the lungs in IPF with xenon magnetic resonance imaging
Jim M. Wild
THORAX (2018)
Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris
Boris Duchemann et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients
Myriam Delaunay et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Pemetrexed-related interstitial lung disease reported from post marketing surveillance (malignant pleural mesothelioma/non-small cell lung cancer)
Keisuke Tomii et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2017)
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death-Ligand 1 Inhibitors in Non-Small Cell Lung Cancer
Monica Khunger et al.
CHEST (2017)
Surfactant protein-D predicts prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer: a case control study
Kota Nakamura et al.
BMC CANCER (2017)
Interstitial lung disease associated with gemcitabine: A Japanese retrospective cohort study
Tsuyoshi Hamada et al.
RESPIROLOGY (2016)
The efficacy and safety of everolimus for the treatment of progressive gastroenteropancreatic neuroendocrine tumors: A multi-institution observational study in Taiwan
Chien-Ting Liu et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2016)
The combination of HLA-B*15:01 and DRB1*15:01 is associated with gemcitabine plus erlotinib-induced interstitial lung disease in patients with advanced pancreatic cancer
Meiko Nishimura et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
PD-1 Inhibitor-Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course
Mizuki Nishino et al.
CLINICAL CANCER RESEARCH (2016)
Gemcitabine-Related Pneumonitis in Pancreas Adenocarcinoma-An Infrequent Event: Elucidation of Risk Factors and Management Implications
Ibrahim Halil Sahin et al.
CLINICAL COLORECTAL CANCER (2016)
Drug-related pneumonitis during mammalian target of rapamycin inhibitor therapy in patients with neuroendocrine tumors: a radiographic pattern-based approach
Mizuki Nishino et al.
EUROPEAN JOURNAL OF CANCER (2016)
Safety of treatment with high-dose daptomycin in 102 patients with infective endocarditis
Emanuele Durante-Mangoni et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Leflunomide Use and Risk of Lung Disease in Rheumatoid Arthritis: A Systematic Literature Review and Metaanalysis of Randomized Controlled Trials
Richard Conway et al.
JOURNAL OF RHEUMATOLOGY (2016)
Evaluation of the Risk of Nitrofurantoin Lung Injury and Its Efficacy in Diminished Kidney Function in Older Adults in a Large Integrated Healthcare System: A Matched Cohort Study
Jody M. Santos et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2016)
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma
Peter Johnson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Interstitial Lung Disease After Kidney Transplantation and the Role of Everolimus
A. Solazzo et al.
TRANSPLANTATION PROCEEDINGS (2016)
Efficacy and safety of gemcitabine plus erlotinib for locally advanced or metastatic pancreatic cancer: a systematic review and meta-analysis
Yuan Wang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Incidence of Programmed Cell Death 1 Inhibitor-Related Pneumonitis in Patients With Advanced Cancer A Systematic Review and Meta-analysis
Mizuki Nishino et al.
JAMA ONCOLOGY (2016)
Characteristics of and Risk Factors for Interstitial Lung Disease Induced by Chemotherapy for Lung Cancer
Takumi Sakurada et al.
ANNALS OF PHARMACOTHERAPY (2015)
Outcome of patients older than 60years with classical Hodgkin lymphoma treated with front line ABVD chemotherapy: frequent pulmonary events suggest limiting the use of bleomycin in the elderly
Aspasia Stamatoullas et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Clinical features and risk factors of panitumumab-induced interstitial lung disease: a postmarketing all-case surveillance study
Masahiro Osawa et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2015)
Bleomycin-Induced Pneumonitis in the Treatment of Ovarian Sex Cord-Stromal Tumors A Systematic Review and Meta-analysis
Nicolas Delanoy et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2015)
Drug-Related Pneumonitis During Mammalian Target of Rapamycin Inhibitor Therapy: Radiographic Pattern-Based Approach in Waldenstrom Macroglobulinemia as a Paradigm
Mizuki Nishino et al.
ONCOLOGIST (2015)
Incidence and complications of interstitial lung disease in users of tocilizumab, rituximab, abatacept and anti-tumor necrosis factor a agents, a retrospective cohort study
Jeffrey R. Curtis et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials
Richard Conway et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials
Richard Conway et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Radiographic Profiling of Immune-Related Adverse Events in Advanced Melanoma Patients Treated with Ipilimumab
Sree Harsha Tirumani et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Risk of interstitial lung disease associated with EGFR-TKIs in advanced non-small-cell lung cancer: a meta-analysis of 24 phase III clinical trials
Wei-Xiang Qi et al.
JOURNAL OF CHEMOTHERAPY (2015)
Final safety and efficacy of erlotinib in the phase 4 POLARSTAR surveillance study of 10 708 Japanese patients with non-small-cell lung cancer
Akihiko Gemma et al.
CANCER SCIENCE (2014)
Association Between Baseline Pulmonary Status and Interstitial Lung Disease in Patients With Non-Small-Cell Lung Cancer Treated With Erlotinib-A Cohort Study
Takeshi Johkoh et al.
CLINICAL LUNG CANCER (2014)
Feasibility assessment of using oxygen-enhanced magnetic resonance imaging for evaluating the effect of pharmacological treatment in COPD
Alexandra R. Morgan et al.
EUROPEAN JOURNAL OF RADIOLOGY (2014)
Panitumumab in Japanese Patients with Unresectable Colorectal Cancer: A Post-marketing Surveillance Study of 3085 Patients
Narikazu Boku et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2014)
Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA
Kumi Shidara et al.
Modern Rheumatology (2014)
Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
Takao Koike et al.
Modern Rheumatology (2014)
Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients
Takao Koike et al.
Modern Rheumatology (2014)
Risk of interstitial lung disease with gefitinib and erlotinib in advanced non-small cell lung cancer: A systematic review and meta-analysis of clinical trials
Liang Shi et al.
LUNG CANCER (2014)
A cohort study of interstitial lung diseases in central Denmark
Charlotte Hyldgaard et al.
RESPIRATORY MEDICINE (2014)
Initial characteristics and outcome of hospitalized patients with amiodarone pulmonary toxicity
J. Mankikian et al.
RESPIRATORY MEDICINE (2014)
Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: A systematic literature review
Camille Roubille et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2014)
Interstitial pneumonitis caused by everolimus: a case-cohort study in renal transplant recipients
Marije C. Baas et al.
TRANSPLANT INTERNATIONAL (2014)
Methotrexate and Lung Disease in Rheumatoid Arthritis
Richard Conway et al.
ARTHRITIS & RHEUMATOLOGY (2014)
The diagnostic utility of chest computed tomography scoring for the assessment of amiodarone-induced pulmonary toxicity
In Sook Kang et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2014)
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
William D. Travis et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
High-Resolution Computed Tomography Findings for Patients With Drug-Induced Pulmonary Toxicity, With Special Reference to Hypersensitivity Pneumonitis-Like Patterns in Gemcitabine-Induced Cases
Masaki Tamura et al.
ONCOLOGIST (2013)
Gemcitabine Plus Erlotinib for Advanced Pancreatic Cancer: A Systematic Review with Meta-Analysis
Zu-Yao Yang et al.
PLOS ONE (2013)
Association between anti-TNF-α therapy and interstitial lung disease
Lisa J. Herrinton et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2013)
Incidence and outcomes of bepridil-induced interstitial pneumonia
Kei Yamasaki et al.
RESPIRATORY MEDICINE (2013)
Serum heat shock protein 47 levels in patients with drug-induced lung disease
Tomoyuki Kakugawa et al.
RESPIRATORY RESEARCH (2013)
Outcome and predictors of mortality in patients requiring invasive mechanical ventilation due to acute respiratory failure while undergoing ambulatory chemotherapy for solid cancers
So Young Park et al.
SUPPORTIVE CARE IN CANCER (2013)
Incidence and risk of pulmonary toxicity in patients treated with mTOR inhibitors for malignancy. A meta-analysis of published trials
Roberto Iacovelli et al.
ACTA ONCOLOGICA (2012)
Eosinophilic Pneumonia in Patients Treated with Daptomycin Review of the Literature and US FDA Adverse Event Reporting System Reports
Peter W. Kim et al.
DRUG SAFETY (2012)
A Japanese Post-marketing Surveillance of Cetuximab (Erbitux) in Patients with Metastatic Colorectal Cancer
Megumi Ishiguro et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2012)
Postmarketing Surveillance Study of Erlotinib in Japanese Patients With Non-Small-Cell Lung Cancer (NSCLC) An Interim Analysis of 3488 Patients (POLARSTAR)
Kazuhiko Nakagawa et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Risk Factors for Treatment-Related Death Associated with Chemotherapy and Thoracic Radiotherapy for Lung Cancer
Yuko Minami-Shimmyo et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Drug-/radiation-induced interstitial lung disease in the United Kingdom general population: Incidence, all-cause mortality and characteristics at diagnosis
Rajeev K. Amar et al.
RESPIROLOGY (2012)
Prognostic impact of bleomycin-induced pneumonitis on the outcome of Hodgkin's lymphoma
Joanne Ngeow et al.
ANNALS OF HEMATOLOGY (2011)
Clarification of clinical features of interstitial lung disease induced by irinotecan based on postmarketing surveillance data and spontaneous reports
Noritoshi Yoshii et al.
ANTI-CANCER DRUGS (2011)
Interstitial lung disease associated with gemcitabine treatment in patients with non-small-cell lung cancer and pancreatic cancer
Shigeki Umemura et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Drug-Related Pneumonitis in Patients With Advanced Renal Cell Carcinoma Treated With Temsirolimus
Jose Pablo Maroto et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Prospective evaluation of drug-induced lung toxicity with high-resolution CT and transbronchial biopsy
S. Piciucchi et al.
RADIOLOGIA MEDICA (2011)
Non-infectious pulmonary complications of newer biological agents for rheumatic diseases-a systematic literature review
Andreas V. Hadjinicolaou et al.
RHEUMATOLOGY (2011)
Interstitial Lung Disease Induced or Exacerbated by TNF-Targeted Therapies: Analysis of 122 Cases
Roberto Perez-Alvarez et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2011)
Change in serum KL-6 level from baseline is useful for predicting life-threatening EGFR-TKIs induced interstitial lung disease
Shigeo Kawase et al.
RESPIRATORY RESEARCH (2011)
Noninfectious Pneumonitis after Everolimus Therapy for Advanced Renal Cell Carcinoma
Dorothy A. White et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Pneumonitis as A Consequence of (Peg)Interferon-Ribavirin Combination Therapy for Hepatitis C: a Review of the Literature
Serena Slavenburg et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Rituximab-induced lung disease: a systematic literature review
H. Liote et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Pulmonary Toxicity after a Quick Course of Combinatorial Vincristine, Bleomycin, and Cisplatin Neoadjuvant Chemotherapy in Cervical Cancer
Kyung-Do Ki et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Severe Pulmonary Adverse Effects in Lymphoma Patients Treated with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) Regimen Plus Rituximab
Kyu-Hyoung Lim et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2010)
Nitrofurantoin Pulmonary Toxicity: Neglected Threat
Emilia Hardak et al.
CURRENT DRUG SAFETY (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Quantitative signal detection using spontaneous ADR reporting
A. Bate et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
Factors associated with fatal outcome of leflunomide-induced lung injury in Japanese patients with rheumatoid arthritis
Takeo Sato et al.
RHEUMATOLOGY (2009)
Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis
Tetsuji Sawada et al.
RHEUMATOLOGY (2009)
Clinical expression of leflunomide-induced pneumonitis
Batsi Chikura et al.
RHEUMATOLOGY (2009)
Sirolimus and Everolimus Induced Pneumonitis in Adult Renal Allograft Recipients: Experience in a Center
A. Rodriguez-Moreno et al.
TRANSPLANTATION PROCEEDINGS (2009)
Interstitial lung disease in Japanese patients with lung cancer - A cohort and nested case-control study
Shoji Kudoh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Statins and Interstitial Lung Disease A Systematic Review of the Literature and of Food and Drug Administration Adverse Event Reports
Antonio B. Fernandez et al.
CHEST (2008)
Role of Cytochrome P450 Polymorphisms in the Development of Pulmonary Drug Toxicity A Case-Control Study in the Netherlands
Petal A. H. M. Wijnen et al.
DRUG SAFETY (2008)
High-resolution computed tomography patterns and immunopathogenetic findings in drug-induced pneumonitis
Keiko Takatani et al.
RESPIRATORY MEDICINE (2008)
Pneumonitis associated with sirolimus: clinical characteristics, risk factors and outcome- a single-centre experience and review of the literature
Stefan M. Weiner et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Incidence and predictors of pulmonary toxicity in Japanese patients receiving low-dose amiodarone
Yuichiro Yamada et al.
CIRCULATION JOURNAL (2007)
Rituximab-induced interstitial lung disease
Stephanie A. Wagner et al.
AMERICAN JOURNAL OF HEMATOLOGY (2007)
Autoimmune diseases induced by TNF-targeted therapies -: Analysis of 233 cases
Manuel Ramos-Casals et al.
MEDICINE (2007)
Characterisation of the lung toxicity of the cell cycle inhibitor temsirolimus
I. Duran et al.
EUROPEAN JOURNAL OF CANCER (2006)
Predictive factors for interstitial lung disease, antitumor response, and survival in non-small-cell lung cancer patients treated with gefitinib
M Ando et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis
Samy Suissa et al.
ARTHRITIS AND RHEUMATISM (2006)
Twenty-seven cases of drug-induced interstitial lung disease associated with imatinib mesylate
K. Ohnishi et al.
LEUKEMIA (2006)
National differences in reporting 'pneumonia' and 'pneumonia interstitial': an analysis of the WHO International Drug Monitoring Database on 15 drugs in nine countries for seven pulmonary conditions
LC Koo et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2005)
High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding study
C Kouroussis et al.
LUNG CANCER (2004)
Circulating KL-6 levels in patients with drug induced pneumonitis
H Ohnishi et al.
THORAX (2003)
Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease
JW Friedberg et al.
CANCER (2003)
Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours
JM O'Sullivan et al.
ANNALS OF ONCOLOGY (2003)
A phase II study of weekly gemcitabine and paclitaxel in patients with previously untreated stage IIIb and IV non-small cell lung cancer
S Bhatia et al.
LUNG CANCER (2002)
Drug-induced pneumonitis: Thin-section CT findings in 60 patients
M Akira et al.
RADIOLOGY (2002)
Drug-induced lung disease:: High-resolution CT and histological findings
JR Cleverley et al.
CLINICAL RADIOLOGY (2002)
Spectrum of CD4 to CD8 T-cell ratios in lymphocytic alveolitis associated with methotrexate-induced pneumonitis
C Fuhrman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Dose-finding, pharmacokinetic and phase II study of docetaxel in combination with gemcitabine in patients with inoperable non-small cell lung cancer
P Rebattu et al.
LUNG CANCER (2001)
Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients
S Imokawa et al.
EUROPEAN RESPIRATORY JOURNAL (2000)
分享论文
